BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 32695810)

  • 1. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
    Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
    Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-210-3p-EphrinA3-PI3K/AKT axis regulates the progression of oral cancer.
    Wang L; Song Y; Wang H; Liu K; Shao Z; Shang Z
    J Cell Mol Med; 2020 Apr; 24(7):4011-4022. PubMed ID: 32180353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
    Wu XG; Zhou CF; Zhang YM; Yan RM; Wei WF; Chen XJ; Yi HY; Liang LJ; Fan LS; Liang L; Wu S; Wang W
    Angiogenesis; 2019 Aug; 22(3):397-410. PubMed ID: 30993566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation.
    He S; Zhang W; Li X; Wang J; Chen X; Chen Y; Lai R
    Bioengineered; 2021 Dec; 12(1):2164-2174. PubMed ID: 34098850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes from microRNA-126 overexpressing mesenchymal stem cells promote angiogenesis by targeting the PIK3R2-mediated PI3K/Akt signalling pathway.
    Zhang L; Ouyang P; He G; Wang X; Song D; Yang Y; He X
    J Cell Mol Med; 2021 Feb; 25(4):2148-2162. PubMed ID: 33350092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p.
    Chen S; Chen X; Luo Q; Liu X; Wang X; Cui Z; He A; He S; Jiang Z; Wu N; Chen P; Yu K; Zhuang J
    Cell Death Dis; 2021 Jul; 12(7):695. PubMed ID: 34257272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
    Zhu X; Zhang H; Xu J
    Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The up-regulation of miR-21 by gastrodin to promote the angiogenesis ability of human umbilical vein endothelial cells by activating the signaling pathway of PI3K/Akt.
    Wang J; Wu M
    Bioengineered; 2021 Dec; 12(1):5402-5410. PubMed ID: 34424813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4.
    Cui Z; Liu QL; Sun SQ; Jiao K; Liu DR; Zhou XC; Huang L
    Neoplasma; 2020 Jan; 67(1):85-92. PubMed ID: 31829025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
    Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
    Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
    Li C; Lin XF; Wang JN; Ren XS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small extracellular vesicles derived from hypoxic mesenchymal stem cells promote vascularized bone regeneration through the miR-210-3p/EFNA3/PI3K pathway.
    Zhuang Y; Cheng M; Li M; Cui J; Huang J; Zhang C; Si J; Lin K; Yu H
    Acta Biomater; 2022 Sep; 150():413-426. PubMed ID: 35850484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
    He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
    Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.